RareCyte, Inc.

Unmatched Clarity in Spatial Biology & Liquid Biopsy

[RareCyte, Inc. @RareCyte]

Successful Orion training at @UBC. 🚀 The Poh Lab is using the Orion spatial proteomics platform to map the tumor immune microenvironment in oral cancer.

#SpatialBiology #SpatialProteomics

[RareCyte, Inc. @RareCyte]

Real or cake? 🎂 It's a tough one, we know.

It was great getting our team together this week and celebrating the launch of Orion HT!

Check out Orion HT on our website to see how close this cake is to the real thing: https://t.co/jhcuwp7La5

[RareCyte, Inc. @RareCyte]

What is the impact of circulating tumor cell testing in clinical research? Hear from @pashtoonkasi (City of Hope) on the insights that CTCs uniquely give you, and how they complement tissue-based and circulating tumor DNA approaches.

#AACR26 #AACR2026 #LiquidBiopsy

[RareCyte, Inc. @RareCyte]

📣 RareCyte announces launch of Orion HT and Orion LE systems, extending the Orion platform across the full continuum of translational research, from early assay development and validation through clinical trial execution.

➡️ Read the press release: https://t.co/HME2HeF7B6

[RareCyte, Inc. @RareCyte]

This study demonstrates the feasibility and robust performance of the CDH17 CTC assay in blood and cerebrospinal fluid of a colorectal cancer patient.

☑️Powered by RareCyte's CyteFinder platform

#AACR2026 #AACR26

[Pashtoon Kasi MD, MS @pashtoonkasi]

#AACR26 See our work that challenges so many dogmas about #LiquidBiopsies for cancer.

⚫️Not just DNA🧬, CTCs👇🏽
⚫️Not just blood, CSF🧠
⚫️Not just prognostic, predictive🎯CDH17
⚫️Kinetics🟰📉response

CSF cytology was negative ➖
So many💡

🔗https://t.co/58dlVyQssy

@OncoAlert

[RareCyte, Inc. @RareCyte]

📍Swing by the RareCyte booth (1823) at #AACR2026 to experience Orion HT, the spatial proteomics platform designed for clinical scale.

View RareCyte’s AACR program: https://t.co/nUhBMnHPYB

#AACR2026 #SpatialProteomics #SpatialBiology

[RareCyte, Inc. @RareCyte]

RareCyte is heading to #AACR2026 in San Diego! Stop by booth #1823 to hear exciting news around advancing spatial proteomics for clinical research.

See our full conference program: https://t.co/nUhBMnHPYB

Book a meeting with us: https://t.co/9ClmEp35g5

#AACR #SpatialBiology

[RareCyte, Inc. @RareCyte]

17-plex single-round imaging of human gastric adenocarcinoma, acquired on the Orion platform. 📸 This image, courtesy of Shumpei Ishikawa, PhD, from @UTokyo_News is featured in the RareCyte 2026 Calendar.

View all images featured this year’s calendar: https://t.co/LsLD5sAnDb

[RareCyte, Inc. @RareCyte]

Biomarker depth with throughput. No compromises.

Introducing Orion HT — 20-channel imaging and 30-slide walkaway automation built for large-scale translational and clinical programs.

Learn more ➡️ https://t.co/CggXTXoi25

#SpatialBiology #SpatialProteomics #OrionSpatial

[RareCyte, Inc. @RareCyte]

Spatial Biology Services ➝ Spatial Biomarker Insights for Translational and Clinical Studies

Analyze tissue biopsies with multiplexed biomarker panels at high throughput, unlocking valuable quantitative insights from large cohort studies. 💡

Learn more: https://t.co/P5EB7wngrD

[RareCyte, Inc. @RareCyte]

Upcoming webinar on easy strategies for reliable spatial biomarker results, presented by Simon Goldstein (@ljiresearch).

Key topics:
✅ Validating antibody performance
✅ Designing and optimizing multiplex panels
✅ Sample preparation tips

Register here: https://t.co/tLY4XKARg1

[RareCyte, Inc. @RareCyte]

💡 #SpatialInsight: Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disease.

This @nyuniversity team examined the immune microenvironment within HS lesions.

➡️ Explore the interactive tissue atlas: https://t.co/qEGtg5QKB7

#Hidradenitis #Autoimmune

[RareCyte, Inc. @RareCyte]

17-plex imaging of renal cell carcinoma, acquired on the Orion platform. 📸

This image, courtesy of Gaurav Shrestha, PhD from the @OhioState is featured in the RareCyte 2026 Calendar.

➡️ View all images from our Calendar Contest: https://t.co/Pvveybe8kN

#RareCyteCalendar

[RareCyte, Inc. @RareCyte]

💥 18-plex imaging of breast duct harboring ductal carcinoma, acquired on the Orion spatial biology platform.

📸 This image, courtesy of Aditi Sanjay Khatpe, Stanford University, is featured in the RareCyte 2026 Calendar.

View all calendar images: https://t.co/LsLD5sAnDb

[RareCyte, Inc. @RareCyte]

Hear how spatial proteomics could change clinical practice in the near future.

Sandro Santagata @BrighamWomens is presenting at #SABCS25 on how multiplex protein analysis enables deeper, more efficient tumor profiling, going beyond single-marker IHC.

➡️ https://t.co/1eNbb7p8Pj

[RareCyte, Inc. @RareCyte]

Heading to #SABCS25 next week? Don’t miss Karthik Giridhar's (@MayoClinic) poster on using CTC enumeration and ER/HER2 phenotyping to predict progression-free and overall survival in metastatic breast cancer.

🔬 Powered by the RareCyte CyteFinder Platform

#AACR #BreastCancer

[RareCyte, Inc. @RareCyte]

RareCyte is honored to be this month's Life Science Washington Member Spotlight!

Read the full spotlight ➡️ https://t.co/Z5hAktAkrD

#LifeScienceWashington #SpatialBiology #LiquidBiopsy

[Life Science WA @LifeScienceWA]

Our next LSW Member Spotlight features @RareCyte! Their technologies are driving major advances in cancer research, immunotherapy development, and next-generation diagnostics by giving scientists insight into rare cells and complex tissue environments.
https://t.co/WLRyHYUF8E

[RareCyte, Inc. @RareCyte]

Labcluster Tour Paris is this week!

Join our presentation on “Spatial Biology at Scale with Orion™ Technology” to discover the only multiplex immunofluorescence platform delivering 20 channels per round.

Register for this free event ➡️ https://t.co/TaH7PantG3

#Labcluster

[RareCyte, Inc. @RareCyte]

RareCyte is proud to sponsor AFC 2025 in Dijon, showcasing innovative platforms designed to complement and extend your cytometry research.

📍Stop by Booth #2 to learn about our spatial biology and liquid biopsy platforms.

Event page: https://t.co/xbaLnTMgYR

[RareCyte, Inc. @RareCyte]

@OhioStatePIIO Amazing work Dr. Shivam Priya & team!